These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1786 related items for PubMed ID: 25434488

  • 1. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
    Isopi E, Granzotto A, Corona C, Bomba M, Ciavardelli D, Curcio M, Canzoniero LM, Navarra R, Lattanzio R, Piantelli M, Sensi SL.
    Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
    [Abstract] [Full Text] [Related]

  • 2. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A, Xu X, Bi X, Baudry M.
    J Alzheimers Dis; 2012 Sep; 30(1):183-208. PubMed ID: 22406441
    [Abstract] [Full Text] [Related]

  • 3. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X, Kosaraju J, Zhou W, Tam KY.
    ACS Chem Neurosci; 2017 Mar 15; 8(3):676-685. PubMed ID: 28032988
    [Abstract] [Full Text] [Related]

  • 4. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
    Peng Y, Hu Y, Xu S, Li P, Li J, Lu L, Yang H, Feng N, Wang L, Wang X.
    J Alzheimers Dis; 2012 Mar 15; 29(2):379-91. PubMed ID: 22233765
    [Abstract] [Full Text] [Related]

  • 5. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH, Wu QY, Zheng R, Chen C, Chen Y, Liu Q, Hoffmann PR, Ni JZ, Song GL.
    J Neurosci; 2017 Mar 01; 37(9):2449-2462. PubMed ID: 28137967
    [Abstract] [Full Text] [Related]

  • 6. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
    Onishi T, Iwashita H, Uno Y, Kunitomo J, Saitoh M, Kimura E, Fujita H, Uchiyama N, Kori M, Takizawa M.
    J Neurochem; 2011 Dec 01; 119(6):1330-40. PubMed ID: 21992552
    [Abstract] [Full Text] [Related]

  • 7. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK, Kim HG, Baek SH, Jung WR, Park DI, Park JS, Jo DG, Kim KL.
    Neurobiol Aging; 2014 May 01; 35(5):990-1001. PubMed ID: 24268884
    [Abstract] [Full Text] [Related]

  • 8. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
    Peng Y, Sun J, Hon S, Nylander AN, Xia W, Feng Y, Wang X, Lemere CA.
    J Neurosci; 2010 Jun 16; 30(24):8180-9. PubMed ID: 20554868
    [Abstract] [Full Text] [Related]

  • 9. Ginkgo biloba Extract EGb 761 and Its Specific Components Elicit Protective Protein Clearance Through the Autophagy-Lysosomal Pathway in Tau-Transgenic Mice and Cultured Neurons.
    Qin Y, Zhang Y, Tomic I, Hao W, Menger MD, Liu C, Fassbender K, Liu Y.
    J Alzheimers Dis; 2018 Jun 16; 65(1):243-263. PubMed ID: 30010136
    [Abstract] [Full Text] [Related]

  • 10. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X, Kosaraju J, Zhou W, Tam KY.
    Neuropharmacology; 2018 Mar 15; 131():351-363. PubMed ID: 29309769
    [Abstract] [Full Text] [Related]

  • 11. Differential Effects of Palmitoylethanolamide against Amyloid-β Induced Toxicity in Cortical Neuronal and Astrocytic Primary Cultures from Wild-Type and 3xTg-AD Mice.
    Tomasini MC, Borelli AC, Beggiato S, Ferraro L, Cassano T, Tanganelli S, Antonelli T.
    J Alzheimers Dis; 2015 Mar 15; 46(2):407-21. PubMed ID: 25765918
    [Abstract] [Full Text] [Related]

  • 12. Systemic pyruvate administration markedly reduces neuronal death and cognitive impairment in a rat model of Alzheimer's disease.
    Wang X, Hu X, Yang Y, Takata T, Sakurai T.
    Exp Neurol; 2015 Sep 15; 271():145-54. PubMed ID: 26057947
    [Abstract] [Full Text] [Related]

  • 13. Short-term modern life-like stress exacerbates Aβ-pathology and synapse loss in 3xTg-AD mice.
    Baglietto-Vargas D, Chen Y, Suh D, Ager RR, Rodriguez-Ortiz CJ, Medeiros R, Myczek K, Green KN, Baram TZ, LaFerla FM.
    J Neurochem; 2015 Sep 15; 134(5):915-26. PubMed ID: 26077803
    [Abstract] [Full Text] [Related]

  • 14. Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.
    Umeda T, Ono K, Sakai A, Yamashita M, Mizuguchi M, Klein WL, Yamada M, Mori H, Tomiyama T.
    Brain; 2016 May 15; 139(Pt 5):1568-86. PubMed ID: 27020329
    [Abstract] [Full Text] [Related]

  • 15. Long-term exposure to ELF-MF ameliorates cognitive deficits and attenuates tau hyperphosphorylation in 3xTg AD mice.
    Hu Y, Lai J, Wan B, Liu X, Zhang Y, Zhang J, Sun D, Ruan G, Liu E, Liu GP, Chen C, Wang DW.
    Neurotoxicology; 2016 Mar 15; 53():290-300. PubMed ID: 26945731
    [Abstract] [Full Text] [Related]

  • 16. Physical exercise protects against Alzheimer's disease in 3xTg-AD mice.
    García-Mesa Y, López-Ramos JC, Giménez-Llort L, Revilla S, Guerra R, Gruart A, Laferla FM, Cristòfol R, Delgado-García JM, Sanfeliu C.
    J Alzheimers Dis; 2011 Mar 15; 24(3):421-54. PubMed ID: 21297257
    [Abstract] [Full Text] [Related]

  • 17. Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xTg-AD Mouse Model of Alzheimer's Disease.
    Kosaraju J, Holsinger RMD, Guo L, Tam KY.
    Mol Neurobiol; 2017 Oct 15; 54(8):6074-6084. PubMed ID: 27699599
    [Abstract] [Full Text] [Related]

  • 18. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
    Herline K, Prelli F, Mehta P, MacMurray C, Goñi F, Wisniewski T.
    Alzheimers Res Ther; 2018 Jun 18; 10(1):54. PubMed ID: 29914551
    [Abstract] [Full Text] [Related]

  • 19. Apomorphine treatment in Alzheimer mice promoting amyloid-β degradation.
    Himeno E, Ohyagi Y, Ma L, Nakamura N, Miyoshi K, Sakae N, Motomura K, Soejima N, Yamasaki R, Hashimoto T, Tabira T, LaFerla FM, Kira J.
    Ann Neurol; 2011 Feb 18; 69(2):248-56. PubMed ID: 21387370
    [Abstract] [Full Text] [Related]

  • 20. Neutralization of TNFSF10 ameliorates functional outcome in a murine model of Alzheimer's disease.
    Cantarella G, Di Benedetto G, Puzzo D, Privitera L, Loreto C, Saccone S, Giunta S, Palmeri A, Bernardini R.
    Brain; 2015 Jan 18; 138(Pt 1):203-16. PubMed ID: 25472798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 90.